Geode Capital Management »

Denali Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $52M 2.5M 20.63
2023-06-30 $68M 2.3M 29.51
2023-03-31 $49M 2.1M 23.04
2022-12-31 $57M 2.0M 27.81
2022-09-30 $55M 1.8M 30.69
2022-06-30 $50M 1.7M 29.43
2022-03-31 $53M 1.6M 32.17
2021-12-31 $73M 1.6M 44.60
2021-09-30 $81M 1.6M 50.45
2021-06-30 $119M 1.5M 78.44
2021-03-31 $72M 1.3M 57.10
2020-12-31 $97M 1.2M 83.76
2020-09-30 $39M 1.1M 35.83
2020-06-30 $26M 1.1M 24.18
2020-03-31 $17M 983k 17.51
2019-12-31 $15M 868k 17.42
2019-09-30 $13M 843k 15.32
2019-06-30 $17M 824k 20.76
2019-03-31 $18M 774k 23.22
2018-12-31 $15M 710k 20.66
2018-09-30 $15M 709k 21.74
2018-06-30 $3.1M 206k 15.25
2018-03-31 $2.9M 148k 19.69